Jim Cramer on Pfizer: “Pfizer Does Not Have Any Earnings Momentum”
Key takeaways
- Jim Cramer on Pfizer: “Pfizer Does Not Have Any Earnings Momentum” Syeda Seirut Javed Thu, May 14, 2026 at 10:40 PM GMT+7 1 min read PFE Pfizer Inc.
- You’re just buying it on that dividend yield of 6.66.
- (NYSE:PFE) develops and sells medicines and vaccines for several health conditions, including heart disease, infections, COVID-19, and rare diseases.
Jim Cramer on Pfizer: “Pfizer Does Not Have Any Earnings Momentum” Syeda Seirut Javed Thu, May 14, 2026 at 10:40 PM GMT+7 1 min read PFE Pfizer Inc. (NYSE:PFE) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. A caller inquired if they should hold, sell, or buy more. In response, Cramer said:
Pfizer does not have any earnings momentum. You’re just buying it on that dividend yield of 6.66. And I’ve gotta tell you, if I want yield, I will go to bonds, not stocks.
Pfizer Inc. (NYSE:PFE) develops and sells medicines and vaccines for several health conditions, including heart disease, infections, COVID-19, and rare diseases. Cramer showed a similar sentiment toward the stock during the May 1 episode, as he commented: